Date of event: estimated.The unique device identifier (udi) is unknown because the part and lot numbers were not provided.Date of implant: estimated: the devices were not returned for evaluation.A review of the lot history records and complaint histories could not be conducted because the part and lot numbers were not provided.Based on the information reviewed, a conclusive cause for the reported difficulties could not be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.Literature title: everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents.The other events listed in the article are filed under other mfr report numbers.
|
This report is filed for the malfunction.It was reported through a research article identifying absorb scaffolds that may be related to the following: cardiac death, thrombosis, myocardial infarction, target lesion re-vascularization, and hospitalization.Additionally, adverse events may be related to malapposition of the scaffold.Specific patient information is documented as unknown.Details are listed in the article, titled: "everolimus-eluting bioresorbable scaffoldsversus everolimus-eluting metallic stents.".
|